Cervical carcinoma: A drug-responsive tumor-experience with combined cisplatin, vinblastine, and bleomycin therapy

Gynecologic Oncology

Volumn 16, Issue 2, 1983, Pages 275-281

  Friedlander, M ^b,c   Kaye, S B ^b   Sullivan, A ^b   Atkinson, K ^a   Elliott, P ^a   Coppleson, M ^a   Houghton, R ^a   Solomon, J ^a   Green, D ^b   Russell, P ^b   Hudson, C N ^b   Langlands, A O ^b   Tattersall, M H N ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Westmead Centre   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; VINBLASTINE; VINCRISTINE;

ADVERSE DRUG REACTION; ALOPECIA; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG THERAPY; FEMALE GENITAL SYSTEM; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; NAUSEA; RESPIRATORY SYSTEM; SKIN TOXICITY; THERAPY; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VINBLASTINE;

EID: 0020579415     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(83)90102-6     Document Type: Article

References (17)

1. Report of advisory committee on cancer registration
2. Management of failures and complications of cancer of the cervix
3. Chemotherapy in the management of advanced or recurrent cervical and endometrial cancer
4. Four drug combination chemotherapy for advanced cervical cancer
5. Reporting results of cancer treatment
6. Cancer of the cervix and screening
7. The integration of chemotherapy into combined modality treatment of solid tumors: VIII Cervical cancer
8. Prognostic value of node metastasis in cancer of the uterine cervix
9. Cisplatinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix
10. Perspectives on research in gynecologic oncology
11. The management of disseminated cervical cancer
12. Bleomycin, vincristine and cisplatinum in the treatment of advanced recurrent squamous cell carcinoma of the cervix
13. Prognostic significance of cervical lesion size and pelvic node metastases in cervical cancer
14. Prognostic factors in cervical cancer—implications in staging and management